Common Contracts
3 similar License and Collaboration Agreement contracts by Five Prime Therapeutics Inc
License and Collaboration Agreement by and between Five Prime Therapeutics, Inc. and Human Genome Sciences, Inc.License and Collaboration Agreement • August 16th, 2013 • Five Prime Therapeutics Inc • Pharmaceutical preparations • New York
• HGS acquires exclusive rights to develop and commercialize FivePrime’s FP-1039 in the United States, Canada and European Union
License and Collaboration Agreement by and between Five Prime Therapeutics, Inc. and Human Genome Sciences, Inc.License and Collaboration Agreement • July 26th, 2013 • Five Prime Therapeutics Inc • Pharmaceutical preparations • New York
• HGS acquires exclusive rights to develop and commercialize FivePrime’s FP-1039 in the United States, Canada and European Union
License and Collaboration Agreement by and between Five Prime Therapeutics, Inc. and Human Genome Sciences, Inc.License and Collaboration Agreement • July 15th, 2013 • Five Prime Therapeutics Inc • Pharmaceutical preparations • New York
• HGS acquires exclusive rights to develop and commercialize FivePrime’s FP-1039 in the United States, Canada and European Union
